相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
该BioSIM 抗人 TRAILR2/CD262/DR5 抗体 (替加珠单抗),生物类似药,科研用途 [ CAS: 918127-53-4]的免疫原请参考该产品的说明书
- 保存条件:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 克隆性:
单克隆
- 适应物种:
Human
- 保质期:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 级别:
科研级别
- 库存:
999
- 供应商:
亚科因(Abbkine)
- 宿主:
Humanized
- 应用范围:
ELISA, FACS, Functional assay, Research in vivo
- 抗体英文名:
TRAILR2/CD262/DR5
- 抗体名:
TRAILR2/CD262/DR5
- 规格:
1mg
BioSIM 抗人 TRAILR2/CD262/DR5 抗体 (替加珠单抗),生物类似药,科研用途
产品概述
BioSIM anti-Human TRAILR2/CD262/DR5 Antibody (Tigatuzumab Biosimilar) 是一种高质量的科研级生物类似抗体,针对人TRAILR2/CD262/DR5抗原。该抗体在无动物成分的严格条件下生产,采用先进的体外无蛋白细胞培养技术,确保高纯度和低批次间差异。此抗体适用于多种癌症研究,特别是乳腺癌、胃癌、非小细胞肺癌(NSCLC)及实体瘤相关研究。
产品信息
- 英文名称:BioSIM anti-Human TRAILR2/CD262/DR5 Antibody (Tigatuzumab Biosimilar), Research Grade
- 中文名称:BioSIM 抗人 TRAILR2/CD262/DR5 抗体 (替加珠单抗),生物类似药,科研用途
- CAS号:918127-53-4
- 产品类型:二抗
- 供应商:InvivoCrown
- 产品货号:SIM0491-1mg
- 产品规格:1mg
- 来源宿主:Humanized
- 反应性:Human
生产特点
该重组生物类似抗体是在无动物成分的设施中生产的,仅使用体外的无蛋白细胞培养技术,确保生产过程不含任何动物源性成分。经过多步骤的纯化过程,其中包括采用Protein A或G的色谱工艺,可提供高纯度和特异性的抗体产品。
研究领域与应用
此抗体在多种癌症研究领域具有重要应用价值:
- 乳腺癌研究
- 胃癌研究
- 非小细胞肺癌(NSCLC)研究
- 实体瘤研究
应用类型:ELISA, FACS, Functional assay, Research in vivo
储存建议
为确保抗体活性和稳定性,请遵循以下储存建议:
- 避免反复冻融,以保持抗体活性
- 短期需求(1-2周):请在4°C下保存
- 最长12个月的储存:请在-20°C下保存
- 长期储存:请在-80°C下保存
注意事项
该BioSIM 抗人 TRAILR2/CD262/DR5 抗体的免疫原性信息请参考该产品的说明书。本产品仅限科研用途,不可用于临床诊断或治疗。
注意:以上信息可能随着产品优化升级等因素产生变动,具体信息请咨询亚科因公司。

BioSIM anti-Human TRAILR2/CD262/DR5 Antibody (Tigatuzumab Biosimilar), Research Grade
Product Overview
BioSIM anti-Human TRAILR2/CD262/DR5 Antibody (Tigatuzumab Biosimilar) is a high-quality research-grade biosimilar antibody targeting human TRAILR2/CD262/DR5 antigen. This antibody is produced under strict animal component-free conditions using advanced animal-free in vitro cell culture technology, ensuring high purity and low inter-batch variation. This antibody is suitable for various cancer research, particularly breast cancer, gastric cancer, non-small cell lung cancer (NSCLC), and solid tumor-related studies.
Product Information
- English Name:BioSIM anti-Human TRAILR2/CD262/DR5 Antibody (Tigatuzumab Biosimilar), Research Grade
- Chinese Name:BioSIM 抗人 TRAILR2/CD262/DR5 抗体 (替加珠单抗),生物类似药,科研用途
- CAS Number:918127-53-4
- Product Type:Secondary Antibody
- Supplier:InvivoCrown
- Catalog Number:SIM0491-1mg
- Specification:1mg
- Source Host:Humanized
- Reactivity:Human
Production Features
This recombinant biosimilar antibody is produced in animal component-free facilities using only animal-free in vitro cell culture technology, ensuring the production process contains no animal-derived components. After a multi-step purification process, including chromatography with Protein A or G, it provides high purity and specificity antibody products.
Research Areas and Applications
This antibody has important applications in various cancer research areas:
- Breast cancer research
- Gastric cancer research
- Non-small cell lung cancer (NSCLC) research
- Solid tumor research
Application Types:ELISA, FACS, Functional assay, Research in vivo
Storage Recommendations
To ensure antibody activity and stability, please follow the storage recommendations below:
- Avoid repeated freeze-thaw cycles to maintain antibody activity
- For short-term needs (1-2 weeks): Store at 4°C
- For storage up to 12 months: Store at -20°C
- For long-term storage: Store at -80°C
Precautions
Please refer to the product manual for immunogenicity information of this BioSIM anti-Human TRAILR2/CD262/DR5 Antibody. This product is for research use only and not for clinical diagnosis or treatment.
Note: The above information may change due to factors such as product optimization and upgrades. For specific information, please consult Yacoin company.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验
技术资料暂无技术资料 索取技术资料






